Rebecca Ihrie
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neural Stem Cells | 12 | 2025 | 143 | 4.220 |
Why?
| Lateral Ventricles | 11 | 2023 | 36 | 4.180 |
Why?
| Tuberous Sclerosis | 5 | 2025 | 49 | 3.340 |
Why?
| Stem Cell Niche | 4 | 2021 | 53 | 2.450 |
Why?
| Glioblastoma | 8 | 2023 | 326 | 1.900 |
Why?
| Brain Neoplasms | 8 | 2023 | 1170 | 1.880 |
Why?
| Hedgehog Proteins | 4 | 2018 | 188 | 1.410 |
Why?
| Neurogenesis | 4 | 2019 | 124 | 1.170 |
Why?
| Adult Stem Cells | 3 | 2022 | 39 | 1.140 |
Why?
| Brain | 8 | 2024 | 2678 | 1.120 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 4 | 2025 | 119 | 1.040 |
Why?
| Signal Transduction | 10 | 2023 | 4924 | 0.980 |
Why?
| DNA Methylation | 3 | 2025 | 607 | 0.940 |
Why?
| Membrane Proteins | 8 | 2011 | 1119 | 0.880 |
Why?
| Zinc Finger Protein Gli3 | 1 | 2022 | 2 | 0.780 |
Why?
| Oligodendrocyte Transcription Factor 2 | 1 | 2022 | 20 | 0.770 |
Why?
| Microscopy | 1 | 2023 | 141 | 0.740 |
Why?
| Printing, Three-Dimensional | 1 | 2021 | 87 | 0.690 |
Why?
| Astrocytoma | 2 | 2019 | 122 | 0.680 |
Why?
| Phosphoproteins | 4 | 2006 | 332 | 0.630 |
Why?
| Trans-Activators | 4 | 2006 | 387 | 0.620 |
Why?
| Cell Lineage | 4 | 2025 | 333 | 0.620 |
Why?
| Software | 1 | 2023 | 607 | 0.580 |
Why?
| Nerve Tissue Proteins | 1 | 2022 | 570 | 0.580 |
Why?
| Morphogenesis | 1 | 2018 | 158 | 0.570 |
Why?
| Flow Cytometry | 6 | 2024 | 1156 | 0.560 |
Why?
| Imaging, Three-Dimensional | 1 | 2021 | 530 | 0.560 |
Why?
| Glioma | 1 | 2021 | 354 | 0.550 |
Why?
| Carcinogenesis | 1 | 2019 | 213 | 0.550 |
Why?
| Tumor Suppressor Protein p53 | 4 | 2006 | 511 | 0.530 |
Why?
| Desmosomes | 3 | 2011 | 21 | 0.510 |
Why?
| Cell Differentiation | 8 | 2025 | 1901 | 0.500 |
Why?
| Neurons | 6 | 2020 | 1511 | 0.490 |
Why?
| Animals | 27 | 2025 | 35346 | 0.480 |
Why?
| Synapses | 1 | 2018 | 400 | 0.470 |
Why?
| Sirtuin 1 | 1 | 2014 | 30 | 0.460 |
Why?
| Induced Pluripotent Stem Cells | 3 | 2025 | 221 | 0.410 |
Why?
| Mice | 20 | 2025 | 16935 | 0.410 |
Why?
| Medulloblastoma | 1 | 2014 | 198 | 0.400 |
Why?
| Repressor Proteins | 1 | 2014 | 406 | 0.370 |
Why?
| Cerebral Ventricles | 1 | 2011 | 50 | 0.370 |
Why?
| Proto-Oncogene Proteins | 1 | 2014 | 637 | 0.360 |
Why?
| Single-Cell Analysis | 3 | 2019 | 277 | 0.350 |
Why?
| Neoplasms | 6 | 2022 | 2469 | 0.340 |
Why?
| Cell Movement | 2 | 2011 | 945 | 0.330 |
Why?
| Humans | 33 | 2025 | 129378 | 0.320 |
Why?
| Apoptosis | 7 | 2019 | 2503 | 0.310 |
Why?
| DNA-Binding Proteins | 2 | 2014 | 1443 | 0.310 |
Why?
| Astrocytes | 2 | 2024 | 201 | 0.290 |
Why?
| Smoothened Receptor | 2 | 2022 | 6 | 0.290 |
Why?
| Stem Cells | 2 | 2011 | 577 | 0.270 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2011 | 821 | 0.270 |
Why?
| Gene Expression Profiling | 3 | 2023 | 1706 | 0.260 |
Why?
| Ectodermal Dysplasia | 1 | 2006 | 16 | 0.250 |
Why?
| Image Cytometry | 2 | 2022 | 7 | 0.250 |
Why?
| DNA Demethylation | 1 | 2025 | 2 | 0.240 |
Why?
| Tumor Suppressor Proteins | 2 | 2023 | 317 | 0.230 |
Why?
| Mouth Mucosa | 1 | 2005 | 89 | 0.230 |
Why?
| Cells, Cultured | 4 | 2022 | 4082 | 0.230 |
Why?
| Microglia | 2 | 2023 | 235 | 0.230 |
Why?
| Tumor Microenvironment | 4 | 2023 | 634 | 0.220 |
Why?
| Enhancer Elements, Genetic | 1 | 2025 | 177 | 0.220 |
Why?
| Cell Adhesion | 5 | 2011 | 452 | 0.220 |
Why?
| Skin | 2 | 2006 | 724 | 0.210 |
Why?
| Blood-Brain Barrier | 1 | 2024 | 132 | 0.210 |
Why?
| Cell Proliferation | 6 | 2021 | 2391 | 0.190 |
Why?
| Disease Susceptibility | 2 | 2019 | 333 | 0.190 |
Why?
| Neoplastic Stem Cells | 2 | 2021 | 380 | 0.190 |
Why?
| Olfactory Bulb | 2 | 2015 | 136 | 0.190 |
Why?
| Nestin | 1 | 2021 | 19 | 0.190 |
Why?
| Chromatin | 1 | 2025 | 479 | 0.180 |
Why?
| Organoids | 1 | 2022 | 104 | 0.180 |
Why?
| Oligodendroglioma | 1 | 2020 | 15 | 0.180 |
Why?
| Cell Nucleus | 2 | 2023 | 582 | 0.180 |
Why?
| Interneurons | 1 | 2022 | 119 | 0.180 |
Why?
| Image Processing, Computer-Assisted | 2 | 2023 | 743 | 0.170 |
Why?
| Unsupervised Machine Learning | 1 | 2020 | 18 | 0.170 |
Why?
| Immunohistochemistry | 2 | 2023 | 1698 | 0.170 |
Why?
| GTPase-Activating Proteins | 1 | 2020 | 81 | 0.170 |
Why?
| X-Ray Therapy | 1 | 2019 | 2 | 0.170 |
Why?
| Corpus Callosum | 2 | 2017 | 66 | 0.160 |
Why?
| Thyroid Nuclear Factor 1 | 1 | 2019 | 15 | 0.160 |
Why?
| Machine Learning | 1 | 2024 | 443 | 0.160 |
Why?
| Drug Resistant Epilepsy | 1 | 2020 | 84 | 0.150 |
Why?
| Animals, Newborn | 1 | 2021 | 835 | 0.150 |
Why?
| Datasets as Topic | 1 | 2019 | 109 | 0.150 |
Why?
| Chemoradiotherapy | 1 | 2019 | 210 | 0.150 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 1356 | 0.140 |
Why?
| Genes, Reporter | 1 | 2017 | 267 | 0.130 |
Why?
| Transgenes | 1 | 2017 | 177 | 0.130 |
Why?
| Zinc Finger Protein GLI1 | 2 | 2015 | 23 | 0.120 |
Why?
| Cell Line, Tumor | 3 | 2019 | 3215 | 0.120 |
Why?
| Survival Analysis | 1 | 2019 | 1272 | 0.120 |
Why?
| Mice, Knockout | 6 | 2012 | 2870 | 0.120 |
Why?
| Macrolides | 1 | 2016 | 63 | 0.120 |
Why?
| Mass Spectrometry | 1 | 2019 | 716 | 0.120 |
Why?
| Angelman Syndrome | 1 | 2015 | 11 | 0.120 |
Why?
| Kruppel-Like Transcription Factors | 2 | 2015 | 67 | 0.120 |
Why?
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 8 | 0.120 |
Why?
| Genomic Imprinting | 1 | 2015 | 33 | 0.120 |
Why?
| Epithelium | 2 | 2006 | 311 | 0.110 |
Why?
| Kaplan-Meier Estimate | 1 | 2016 | 857 | 0.110 |
Why?
| Mutation | 1 | 2025 | 3717 | 0.110 |
Why?
| Age Factors | 2 | 2011 | 3144 | 0.110 |
Why?
| ErbB Receptors | 1 | 2017 | 607 | 0.110 |
Why?
| Transcription Factors | 2 | 2016 | 1650 | 0.110 |
Why?
| Oligodendroglia | 1 | 2015 | 166 | 0.110 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2015 | 153 | 0.110 |
Why?
| Female | 8 | 2024 | 68686 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2019 | 5438 | 0.100 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 69 | 0.100 |
Why?
| Proteomics | 1 | 2019 | 1062 | 0.100 |
Why?
| S100 Calcium Binding Protein G | 1 | 2011 | 7 | 0.090 |
Why?
| Calbindins | 1 | 2011 | 5 | 0.090 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1565 | 0.090 |
Why?
| Stilbamidines | 1 | 2011 | 10 | 0.090 |
Why?
| Choline O-Acetyltransferase | 1 | 2011 | 24 | 0.090 |
Why?
| Germ Layers | 1 | 2011 | 7 | 0.090 |
Why?
| Estrogen Antagonists | 1 | 2011 | 45 | 0.090 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2011 | 73 | 0.090 |
Why?
| Cytarabine | 1 | 2011 | 57 | 0.090 |
Why?
| Tomography, X-Ray Computed | 1 | 2021 | 2528 | 0.090 |
Why?
| Circadian Rhythm | 1 | 2015 | 413 | 0.090 |
Why?
| Odontogenesis | 1 | 2011 | 11 | 0.090 |
Why?
| Dental Enamel | 1 | 2011 | 69 | 0.090 |
Why?
| Sirolimus | 2 | 2024 | 266 | 0.090 |
Why?
| Tamoxifen | 1 | 2011 | 200 | 0.090 |
Why?
| Luminescent Proteins | 1 | 2011 | 175 | 0.090 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 212 | 0.080 |
Why?
| Gene Expression | 2 | 2015 | 1471 | 0.080 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2011 | 206 | 0.080 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2012 | 814 | 0.080 |
Why?
| Disease Progression | 1 | 2016 | 2626 | 0.080 |
Why?
| Mice, Transgenic | 2 | 2011 | 2119 | 0.070 |
Why?
| Heterozygote | 2 | 2006 | 272 | 0.070 |
Why?
| Phenotype | 1 | 2016 | 3076 | 0.070 |
Why?
| Blotting, Northern | 2 | 2004 | 200 | 0.070 |
Why?
| Child, Preschool | 2 | 2019 | 10516 | 0.060 |
Why?
| Immunosuppressive Agents | 1 | 2011 | 848 | 0.060 |
Why?
| Male | 5 | 2019 | 63595 | 0.060 |
Why?
| Adult | 4 | 2019 | 35512 | 0.060 |
Why?
| Child | 4 | 2020 | 20868 | 0.060 |
Why?
| Papilloma | 1 | 2005 | 46 | 0.060 |
Why?
| Hair | 1 | 2006 | 73 | 0.060 |
Why?
| Desmoplakins | 1 | 2005 | 19 | 0.060 |
Why?
| Genes, Tumor Suppressor | 1 | 2005 | 86 | 0.060 |
Why?
| Epidermis | 1 | 2006 | 155 | 0.060 |
Why?
| CpG Islands | 1 | 2025 | 152 | 0.060 |
Why?
| Cytoskeletal Proteins | 1 | 2005 | 146 | 0.060 |
Why?
| Blotting, Southern | 1 | 2003 | 69 | 0.050 |
Why?
| RNA, Messenger | 1 | 2011 | 2707 | 0.050 |
Why?
| In Situ Nick-End Labeling | 1 | 2003 | 124 | 0.050 |
Why?
| Keratinocytes | 1 | 2005 | 242 | 0.050 |
Why?
| Proto-Oncogene Proteins c-myc | 1 | 2004 | 132 | 0.050 |
Why?
| Mutant Proteins | 1 | 2023 | 99 | 0.050 |
Why?
| Mice, Mutant Strains | 1 | 2003 | 298 | 0.050 |
Why?
| Phagocytes | 1 | 2023 | 97 | 0.050 |
Why?
| Fetal Development | 1 | 2005 | 286 | 0.050 |
Why?
| Adolescent | 2 | 2019 | 20378 | 0.050 |
Why?
| Gene Expression Regulation | 1 | 2011 | 2548 | 0.050 |
Why?
| Phagocytosis | 1 | 2023 | 362 | 0.050 |
Why?
| Lymphocytes | 1 | 2023 | 375 | 0.050 |
Why?
| Hepatocytes | 2 | 2017 | 216 | 0.040 |
Why?
| Cell Separation | 2 | 2017 | 316 | 0.040 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2022 | 253 | 0.040 |
Why?
| Time Factors | 1 | 2011 | 6550 | 0.040 |
Why?
| Erlotinib Hydrochloride | 1 | 2020 | 70 | 0.040 |
Why?
| Microscopy, Fluorescence | 2 | 2017 | 400 | 0.040 |
Why?
| Malformations of Cortical Development | 1 | 2020 | 14 | 0.040 |
Why?
| Myocardium | 1 | 2006 | 980 | 0.040 |
Why?
| Haploinsufficiency | 1 | 2020 | 48 | 0.040 |
Why?
| Remission Induction | 1 | 2020 | 272 | 0.040 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2019 | 69 | 0.040 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2019 | 37 | 0.040 |
Why?
| Drug Resistance | 1 | 2019 | 166 | 0.040 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 232 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2020 | 939 | 0.040 |
Why?
| Mice, SCID | 2 | 2012 | 351 | 0.040 |
Why?
| Models, Biological | 1 | 2005 | 1719 | 0.040 |
Why?
| DNA Repair | 1 | 2019 | 207 | 0.040 |
Why?
| Skin Neoplasms | 1 | 2005 | 823 | 0.040 |
Why?
| Amphiregulin | 1 | 2017 | 25 | 0.030 |
Why?
| Transcriptome | 1 | 2023 | 887 | 0.030 |
Why?
| Karnofsky Performance Status | 1 | 2017 | 38 | 0.030 |
Why?
| Cerebral Cortex | 1 | 2020 | 436 | 0.030 |
Why?
| Leukocyte Common Antigens | 1 | 2016 | 82 | 0.030 |
Why?
| Jurkat Cells | 1 | 2016 | 134 | 0.030 |
Why?
| Embryo, Mammalian | 1 | 2017 | 226 | 0.030 |
Why?
| Cryopreservation | 1 | 2017 | 97 | 0.030 |
Why?
| Blotting, Western | 2 | 2012 | 1205 | 0.030 |
Why?
| A549 Cells | 1 | 2016 | 59 | 0.030 |
Why?
| Aging | 1 | 2006 | 1776 | 0.030 |
Why?
| Staining and Labeling | 1 | 2016 | 141 | 0.030 |
Why?
| Green Fluorescent Proteins | 1 | 2017 | 385 | 0.030 |
Why?
| HLA-DR Antigens | 1 | 2016 | 224 | 0.030 |
Why?
| Protein Transport | 1 | 2017 | 428 | 0.030 |
Why?
| Macrophages | 1 | 2023 | 1480 | 0.030 |
Why?
| Chronotherapy | 1 | 2015 | 3 | 0.030 |
Why?
| ARNTL Transcription Factors | 1 | 2015 | 16 | 0.030 |
Why?
| Pilot Projects | 1 | 2020 | 1587 | 0.030 |
Why?
| Precision Medicine | 1 | 2019 | 387 | 0.030 |
Why?
| Biological Transport | 1 | 2016 | 401 | 0.030 |
Why?
| Fluorescent Dyes | 1 | 2016 | 317 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2019 | 1835 | 0.030 |
Why?
| Antigens, CD | 1 | 2016 | 489 | 0.030 |
Why?
| Recombinant Proteins | 1 | 2017 | 1304 | 0.030 |
Why?
| Gene Deletion | 1 | 2015 | 379 | 0.030 |
Why?
| Proteins | 1 | 2019 | 940 | 0.030 |
Why?
| Aged, 80 and over | 2 | 2017 | 7069 | 0.030 |
Why?
| Algorithms | 1 | 2020 | 1620 | 0.030 |
Why?
| Prognosis | 1 | 2020 | 3791 | 0.020 |
Why?
| Liver | 2 | 2015 | 1839 | 0.020 |
Why?
| Intestinal Mucosa | 1 | 2017 | 590 | 0.020 |
Why?
| Analysis of Variance | 1 | 2015 | 1287 | 0.020 |
Why?
| Sleep Wake Disorders | 1 | 2015 | 252 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 169 | 0.020 |
Why?
| Ameloblasts | 1 | 2011 | 1 | 0.020 |
Why?
| Olfactory Pathways | 1 | 2011 | 60 | 0.020 |
Why?
| Tooth | 1 | 2011 | 41 | 0.020 |
Why?
| Microarray Analysis | 1 | 2011 | 122 | 0.020 |
Why?
| Body Weight | 1 | 2015 | 940 | 0.020 |
Why?
| Mice, Nude | 1 | 2012 | 683 | 0.020 |
Why?
| Piperazines | 1 | 2012 | 342 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2019 | 4061 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2012 | 1245 | 0.020 |
Why?
| Indoles | 1 | 2012 | 385 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 478 | 0.020 |
Why?
| Sulfonamides | 1 | 2012 | 496 | 0.020 |
Why?
| Phosphorylation | 1 | 2012 | 1713 | 0.020 |
Why?
| Keratin-15 | 1 | 2006 | 14 | 0.020 |
Why?
| Genes, Lethal | 1 | 2006 | 29 | 0.020 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 24 | 0.020 |
Why?
| Keratin-5 | 1 | 2006 | 50 | 0.020 |
Why?
| Cell Growth Processes | 1 | 2005 | 52 | 0.020 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2005 | 149 | 0.020 |
Why?
| Genes, p53 | 1 | 2005 | 70 | 0.020 |
Why?
| Aged | 2 | 2017 | 22052 | 0.010 |
Why?
| Keratins | 1 | 2006 | 175 | 0.010 |
Why?
| Carcinogens | 1 | 2005 | 110 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2017 | 3398 | 0.010 |
Why?
| Gene Silencing | 1 | 2005 | 190 | 0.010 |
Why?
| Ki-67 Antigen | 1 | 2004 | 109 | 0.010 |
Why?
| Neoplasm Transplantation | 1 | 2004 | 257 | 0.010 |
Why?
| Middle Aged | 2 | 2017 | 31102 | 0.010 |
Why?
| Neoplasm Invasiveness | 1 | 2004 | 481 | 0.010 |
Why?
| DNA Replication | 1 | 2004 | 228 | 0.010 |
Why?
| Cell Division | 1 | 2004 | 796 | 0.010 |
Why?
| Heart | 1 | 2006 | 637 | 0.010 |
Why?
| Alleles | 1 | 2004 | 845 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 2004 | 1037 | 0.010 |
Why?
| Young Adult | 1 | 2017 | 12415 | 0.010 |
Why?
| Infant, Newborn | 1 | 2011 | 5760 | 0.010 |
Why?
| Molecular Sequence Data | 1 | 2004 | 2831 | 0.010 |
Why?
| Retrospective Studies | 1 | 2017 | 14498 | 0.010 |
Why?
| Infant | 1 | 2011 | 9023 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2005 | 2281 | 0.010 |
Why?
|
|
Ihrie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|